For more than four decades, Fenwick & West LLP has helped some of the world’s most recognized companies become, and remain, market leaders. From emerging enterprises to large public corporations, our clients are leaders in the technology, life sciences and cleantech sectors and are fundamentally changing the world through rapid innovation.  MORE >

Fenwick & West was founded in 1972 in the heart of Silicon Valley—before “Silicon Valley” existed—by four visionary lawyers who left a top-tier New York law firm to pursue their shared belief that technology would revolutionize the business world and to pioneer the legal work for those technological innovations. In order to be most effective, they decided they needed to move to a location close to primary research and technology development. These four attorneys opened their first office in downtown Palo Alto, and Fenwick became one of the first technology law firms in the world.  MORE >

From our founding in 1972, Fenwick has been committed to promoting diversity and inclusion both within our firm and throughout the legal profession. For almost four decades, the firm has actively promoted an open and inclusive work environment and committed significant resources towards improving our diversity efforts at every level.  MORE >

FLEX by Fenwick is the only service created by an AmLaw 100 firm that provides flexible and cost-effective solutions for interim in-house legal needs to high-growth companies.  MORE >

Fenwick & West handles significant cross-border legal and business issues for a wide range of technology and life sciences who operate internationally..  MORE >

At Fenwick, we are proud of our commitment to the community and to our culture of making a difference in the lives of individuals and organizations in the communities where we live and work. We recognize that providing legal services is not only an essential part of our professional responsibility, but also an excellent opportunity for our attorneys to gain valuable practical experience, learn new areas of the law and contribute to the community.  MORE >

Year after year, Fenwick & West is honored for excellence in the legal profession. Many of our attorneys are recognized as leaders in their respective fields, and our Corporate, Tax, Litigation and Intellectual Property Practice Groups consistently receive top national and international rankings, including:

  • Named Technology Group of the Year by Law360
  • Ranked #1 in the Americas for number of technology deals in 2015 by Mergermarket
  • Nearly 20 percent of Fenwick partners are ranked by Chambers
  • Consistently ranked among the top 10 law firms in the U.S. for diversity
  • Recognized as having top mentoring and pro bono programs by Euromoney


We take sustainability very seriously at Fenwick. Like many of our clients, we are adopting policies that reduce consumption and waste, and improve efficiency. By using technologies developed by a number of our cleantech clients, we are at the forefront of implementing sustainable policies and practices that minimize environmental impact. In fact, Fenwick has earned recognition in several areas as one of the top US law firms for implementing sustainable business practices.  MORE >

At Fenwick, we have a passion for excellence and innovation that mirrors our client base. Our firm is making revolutionary changes to the practice of law through substantial investments in proprietary technology tools and processes—allowing us to deliver best-in-class legal services more effectively.   MORE >

Mountain View Office
Silicon Valley Center
801 California Street
Mountain View, CA 94041

San Francisco Office
555 California Street
12th Floor
San Francisco, CA 94104

Seattle Office
1191 Second Avenue
10th Floor
Seattle, WA 98101

New York Office
1211 Avenue of the Americas
32nd Floor
New York, NY 10036

Shanghai Office
Unit 908, 9/F, Kerry Parkside Office
No. 1155 Fang Dian Road
Pudong New Area, Shanghai 201204
P.R. China
+86 21 8017 1200

Stephen M. Graham

Industry Lead, Life Sciences

Partner, Corporate  

Seattle 206.389.4520


Stephen Graham is co-chair of Fenwick & West’s Life Sciences Practice and Managing Partner of the Seattle Office.

Stephen concentrates in the areas of private and public mergers and acquisitions, public offerings, private placements, and corporate governance matters, including advising boards of directors and audit, compensation and nominating/corporate governance committees, preparation and filing of periodic SEC reports, and other securities law compliance, including Sarbanes-Oxley Act matters and disclosure issues with respect to Rule 10b-5 and Regulation FD.

His diverse practice is focused on the representation of emerging and established high growth companies, essentially serving as an extension of the senior management teams and boards of directors. Stephen has represented companies and investment banks in numerous initial public offerings, a wide variety of merger and acquisition transactions, and private offerings of debt and equity.

Stephen has been recognized by Chambers USA as one of the top corporate and mergers and acquisitions lawyers in Washington. He is also a “Super Lawyer” award recipient, 2000 - 2014, is listed in Who’s Who in America by Marquis Biographical Reference, has been recognized as one of The Best Lawyers in America, and is a member of Pi Sigma Alpha. Stephen was also recognized as a “Life Sciences Star” for his outstanding transactional work in Euromoney’s LMG Life Sciences 2012 and 2013.

In 2011, Stephen was appointed co-chairperson of the Securities and Exchange Commission’s Advisory Committee on Small and Emerging Companies and continues to serve in that position. In 2015, he was named "one of the 19 most influential people in D.C. who can affect your small business" by The Washington Post for his role with the SEC. He is active in community affairs, currently serving on the Board of Directors of the Fred Hutchinson Cancer Research Center, the Institute for Systems Biology and the Washington Biotechnology & Biomedical Association, where he serves on the Executive Committee. He is also a member of the Bank of Montreal Financial Group Washington Advisory Board and serves on the Editorial Board of eHealth Law & Policy.

Prior to joining Fenwick & West, Stephen was a corporate partner with Orrick, Herrington & Sutcliffe LLP, where he was the chair of the global Corporate Practice Group.

Representative Clients:

  • Accelerator Corporation
  • Cardeas Pharma Corp.
  • Cardiac Dimensions, Inc.
  • Institute for Systems Biology
  • Marine Construction Technologies
  • NaviSonics, Inc.
  • Omeros Corporation
  • ProNAi Therapeutics, Inc.
  • Resolute Medical, Inc.
  • Sound Pharmaceuticals, Inc.
  • Speshio, Inc.
  • Teikoku Pharma USA, Inc.
  • Theraclone Sciences, Inc.
  • VentiRx Pharmaceuticals, Inc.
  • Vicis, Inc.​

Represented the following corporations until their acquisition:

  • ​Amnis Corporation
  • Corixa Corporaiton
  • Corus Pharma, Inc.
  • ICOS Corporation
  • Immunex Corporation
  • InControl, Inc.
  • LipoSonix, Inc.
  • SonoSite, Inc.
  • WatchGuard Technologies, Inc.
  • ZymoGenetics, Inc.